The manufacturer announced this week it had reached a $2.7 billion deal to acquire Kito Crosby Ltd. The all-cash transaction ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

China’s Contemporary Amperex Technology (CATL), the world’s largest producer of batteries for electric vehicles and a supplier for Tesla, has applied for a listing in Hong Kong, setting sights on one ...

Wang Yun’an, the 38-year-old founder of Chinese milk tea company Guming Holdings, has become a billionaire after the chain ...

Olix Pharmaceuticals Inc. walked the talk in realizing a new $630 million licensing deal with Eli Lilly and Co. for its cardiovascular and metabolic disease asset, OLX-702A (OLX-75016), rallying stock ...

This is the shocking moment an iPhone user went on a rampage - because he forgot his Apple ID password. The customer, Kirin, 26, became frustrated while having his handset repaired at a service centre ...

Muang Thong United prevailed 2-1 over Chiang Rai United at home in a clash of former Thai League 1 champions on Saturday ...

Apple’s switch could result in a $7.7 billion revenue impact by FY2028, but Qualcomm's strong non-Apple relationships and ...

Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced ...

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial in patients with relapsed/refractory ...

BTIG analyst Justin Zelin downgraded Kura Oncology stock (NASDAQ:KURA) from Buy to Neutral. Zelin cited concerns over the recent KOMET-001 study results for the company's drug, ziftomenib. The ...